Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
University of Arizona
University of Virginia
German Cancer Research Center
Pfizer
Becton, Dickinson and Company
Seagen Inc.
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
University of Chicago
University of Kansas Medical Center
Sesen Bio, Inc.
Sesen Bio, Inc.
Ministry of Scientific Research and Information Technology, Poland